| Literature DB >> 25978465 |
Dorcas M Kamuya1, Sally J Theobald2, Vicki Marsh3, Michael Parker4, Wenzel P Geissler5, Sassy C Molyneux3.
Abstract
Consent processes have attracted significant research attention over the last decade, including in the global south. Although relevant studies suggest consent is a complex negotiated process involving multiple actors, most guidelines assume consent is a one-off encounter with a clear 'yes' or 'no' decision. In this paper we explore the concept of 'silent refusals', a situation where it is not clear whether potential participants want to join studies or those in studies want to withdraw from research, as they were not actively saying no. We draw on participant observation, in-depth interviews and group discussions conducted with a range of stakeholders in two large community based studies conducted by the KEMRI Wellcome Trust programme in coastal Kenya. We identified three broad inter-related rationales for silent refusals: 1) a strategy to avoid conflicts and safeguard relations within households, - for young women in particular-to appear to conform to the wishes of elders; 2) an approach to maintain friendly, appreciative and reciprocal relationships with fieldworkers, and the broader research programme; and 3) an effort to retain study benefits, either for individuals, whole households or wider communities. That refusals and underlying rationales were silent posed multiple dilemmas for fieldworkers, who are increasingly recognised to play a key interface role between researchers and communities in many settings. Silent refusals reflect and reinforce complex power relations embedded in decisions about research participation, with important implications for consent processes and broader research ethics practice. Fieldworkers need support to reflect upon and respond to the ethically charged environment they work in.Entities:
Mesh:
Year: 2015 PMID: 25978465 PMCID: PMC4433355 DOI: 10.1371/journal.pone.0126671
Source DB: PubMed Journal: PLoS One ISSN: 1932-6203 Impact factor: 3.240
Criteria considered in selecting the Community–based studies.
| Criteria | Justification |
|---|---|
| Number of fieldworkers | Selected studies with more than one FW to be able to cross check information across different respondents, minimise responder bias—the tendency to respond desirably and explore FWs dynamics in a team |
| Where FWs were based | Studies with community-based FWs selected to |
| enable exploration of how social embeddedness of FWs might influence research participation | |
| Participants would easily understand who FWs are, as opposed to ward-based FWs who may be mistaken for doctors | |
| Amount of interaction with participants | Selected on-going studies with considerable FW-participant interaction to minimise recall bias, and to learn nature of those interactions |
| studies involving different amounts of interactions i.e. entire household, vs an individual participants | |
| studies at different stages of the research cycle as likely to affect nature of interactions | |
| Sensitivity of procedure or information and levels of benefits | sensitivities around study procedures likely to impact on amount of time taken, range of issues FWs encountered, and nature of relationship between FWs and the participants |
| selected studies with different study procedures which are considered sensitive (e.g. included blood/nasal swabbing/vaccine) |
Key features of the two community based case studies.
| Feature | RSV-study | Malaria-study |
|---|---|---|
| Study question/ objective | Who is infecting whom in the household with Respiratory Synctial Virus (RSV) | Evaluate the efficacy of a ‘promising’ malaria candidate vaccine against malaria disease in infants and children, and across diverse malaria transmission settings in Africa. |
| The study aimed to address key safety and efficacy information required for vaccine licensure | ||
| Study design | Basic science descriptive study. | Double blind (observer blind), randomized, controlled, multi-centre study. |
| Study period | Oct 2009–April 2010; participant involvement for 6 months. | 2008–2015, participants’ involvement for 34 months. |
| Number of study sites | One site in KEMRI-WT, Kilifi. | Eleven sites in seven countries; Burkina Faso, Gabon, Ghana, Kenya, Malawi, Mozambique and Tanzania. |
| Study area in Kilifi | One location, 15 kms from the Kilifi District Hospital (KCH), within KHDSS. | Three administrative divisions, 30 kms from KCH, 5 locations, in Kilifi County. |
| Composition of study team | 16 team members which consisted shared staff | 47 staff which included shared staff |
| Participants | Entire household in a defined locality with an infant born after previous RSV epidemic and at least one elder sibling to the infant. Household defined as all members of a homestead who share at least one meal a day. | Children aged 6–12 weeks and 5–17 months at first vaccination; 16,000 children across the 11 sites, a minimum of 6,000 in each of the age category. |
| Study procedures | Follow-up visits at home every 3–4 days; data from each HH member collected at each visit included: | Randomisation to one of three groups; Experimental malaria vaccine and its booster at 1.5 years |
| Temperature measurement, a nasopharyngeal flocked swab (NFS); history of respiratory illness | Experimental malaria vaccine and a different booster dose of either Meningitis and septicaemia vaccine; and | |
| In addition, respiratory rate taken for all children under 5 years. | Three doses of rabies vaccine plus a different booster doses of Meningitis and septicaemia. | |
| Flocked oral swab (taken at alternate visits (once a week).A demographic and risk assessment questionnaire administered at beginning and end of the study. |
| |
| Risks | Mild discomfort during NSF taking, and time inconveniences. | Detailed side effects as is typical of vaccines trials provided in the study protocol and informed consent; includes severe (such as convulsions, diarrhoea) and mild events (e.g. pain, swelling at vaccination site). |
| Benefits |
|
|
| Other benefits/token staggered throughout the study period included two chairs to each household, sweets, educational materials and token | Free referral for specialized treatment where required, all costs at government facilities covered while transport is provided for first visit to non-government facilities. | |
| All transport to and from the hospital provided by the study team and meals provided for participant and accompanying parents/guardian for al clinic visits. | ||
|
|
| |
| Provision of emergency medical aid during cholera epidemic including drugs, staff, referrals. |
*These staff were shared with other studies within the department
**Token given at the end of the study were said to be the study teams appreciation to participants for having persevered until the end of the study. They included educational materials, food items, clothes to family members
Demographic characteristics of respondents.
| Socio-demographic characteristic | RSV-study (Number) | Malaria-study (Number) |
|---|---|---|
|
| ||
| Total number | 10 | 26 |
| Gender (female) | 3/10 | 1/26 |
| Mean age, years (range) | 26.5 (20–34) | 27.81 (21–38) |
| <24 years | 4 | 7 |
| 25–29 | 3 | 10 |
| 30–34 | 3 | 6 |
| 35–39 | 9 | 12 |
| Marital status (married) | 2 | 9 |
| Education, average (range) years of schooling | 12.2 (12–14) | 12.31 (12–14) |
| 12 years—O-level- | 9 | 22 |
| 14 years—College/diploma | 1 | 4 |
| Average period (months) worked at KWTRP | 7.3 (5–9) | 10.13 (0.1–16) |
| < = 5 months | 4 | 5 |
| 6–10 months, | 6 | 9 |
| 11–15 months, | None | 4 |
| 16–20 months, | None | 8 |
| Number of FWs with relatives participating in the study | 1 | 11 |
| Contract period offered | 9 months | 2 years |
|
| ||
| Total number | 1 | 5 |
| Gender (males, %) | 1 (100%) | 5 (100%) |
| Age in years (mean, range) | 36 years | 29.2 (25–35) |
| 24–29yrs, (number, %) | N/A | 3 (60) |
| 30–34yrs | N/A | 2 (20) |
| 35–39yrs | 1 (100) | 2 (20) |
| Employment duration (mean, range) | 12 years | 4.8 (3–8) |
| 1–5yrs, (number, %) | N/A | 3 (60) |
| 6–10yrs | N/A | 2 (40) |
| 11–15yrs | 1 | N/A |
|
| ||
| Number of respondent for social science study | 16 | 29 |
| Gender (female) | 11/16 (69%) | 15/29 (52%) |
| Age in years (mean, range) | 26.2 (20–40) | 34.9 (18–63) |
| <24 years (number, %) | 4 (25) | 4 (14) |
| 25–34 | 10(63) | 12 (45) |
| 35–44 | 2 (13) | 9 (31) |
| 45–54 | 2 (7) | |
| >55 | 2 (7) | |
| Education levels (Number, %) | ||
| None | 3 (19) | 9 (31) |
| 1–4 years | 6 (38) | 7 (24) |
| 5–8 years | 7 (44) | 12 (41) |
| 9–12 years | 1 (3) |
*as at the time of collecting the data in early 2010.
Summary of interview methods and respondents.
| Interview type | Respondents |
|---|---|
| In-depth interviews (IDI) | 6 IDIs with RSV-study researchers, two each with PI, Study coordinator, Senior FW |
| 1 IDI with one FW in the Malaria-study | |
| Natural group discussions | 5 Natural (household) group discussions with 16 adults participating in the RSV-study |
| Focus Group Discussions (FGD) | 3 FGDs with 10 FWs in the RSV-study (one group interviewed twice) |
| 3 FGDs with 26 Field workers in the Malaria-study | |
| 4 FGDs with 24 participants (grouped per gender) in the Malaria-study | |
| 1 FGD with 5 SFW in the Malaria-study |
Fig 2Consenting process for RSV-study.
Fig 3Consenting process for Malaria-Study.